The aim of the NOCA is to evaluate the patterns of care and outcomes for patients with ovarian cancer in England and Wales.
📅 Webinar: 27 Nov | 🕥 10:30–12:00 GMT
Find out more about the agenda, and join us to explore how to drive improvements in cancer care.
🔗 buff.ly/Murx42E
#LondonGlobalCancerWeek #LGCW2025
📅 Webinar: 27 Nov | 🕥 10:30–12:00 GMT
Find out more about the agenda, and join us to explore how to drive improvements in cancer care.
🔗 buff.ly/Murx42E
#LondonGlobalCancerWeek #LGCW2025
Learn more about ovarian cancer and key findings about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/x99UfX3
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
Learn more about ovarian cancer and key findings about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/x99UfX3
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
She shared insights on the NOCA State of the Nation report and upcoming QI Intervention.
Missed it? Catch up here: buff.ly/RsaLo4B
She shared insights on the NOCA State of the Nation report and upcoming QI Intervention.
Missed it? Catch up here: buff.ly/RsaLo4B
Thanks to NOCA Clinical Fellow, Dr Georgia Zachou, who shared valuable insights on the NOCA report.
Missed it? Catch up here: buff.ly/OQMK5q6
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
Thanks to NOCA Clinical Fellow, Dr Georgia Zachou, who shared valuable insights on the NOCA report.
Missed it? Catch up here: buff.ly/OQMK5q6
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
www.natcan.org.uk/data/
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
www.natcan.org.uk/data/
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
📲Read the report by @noca-natcan.bsky.social @natcan-news.bsky.social @hqip.bsky.social: www.hqip.org.uk/resource/633...
#OvarianCancer #Cancer
📲Read the report by @noca-natcan.bsky.social @natcan-news.bsky.social @hqip.bsky.social: www.hqip.org.uk/resource/633...
#OvarianCancer #Cancer
Read about patients diagnosed in England in 2022 and in Wales in 2022-2023
buff.ly/oLr7Z7J
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Read about patients diagnosed in England in 2022 and in Wales in 2022-2023
buff.ly/oLr7Z7J
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Join us on Monday 13 October for our NATCAN webinars, chaired by Prof Ajay Aggarwal, where we will be sharing key findings from the 2025 SotN reports.
To book tickets and find out more, visit our website👇
buff.ly/ngyfOse
Admission is free.
Join us on Monday 13 October for our NATCAN webinars, chaired by Prof Ajay Aggarwal, where we will be sharing key findings from the 2025 SotN reports.
To book tickets and find out more, visit our website👇
buff.ly/ngyfOse
Admission is free.
buff.ly/dcBGnFG
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
buff.ly/dcBGnFG
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
All 10 national cancer audits are now in one place: bowel, OG, NHL, lung, ovarian, kidney, prostate, pancreatic, primary breast & metastatic breast.
Plus refreshed QI & new sections have been added, check it out here 👉 natcan.org.uk
All 10 national cancer audits are now in one place: bowel, OG, NHL, lung, ovarian, kidney, prostate, pancreatic, primary breast & metastatic breast.
Plus refreshed QI & new sections have been added, check it out here 👉 natcan.org.uk
buff.ly/C2XYSW7
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
buff.ly/C2XYSW7
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Read about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/dOTZClC
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Read about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/dOTZClC
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Great to see such strong engagement from the gynae-oncology community! 🙌
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Great to see such strong engagement from the gynae-oncology community! 🙌
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Explore the latest data insights and performance indicator updates.
🔗 buff.ly/nkA9hR6
@natcan-news.bsky.social @targetovarian.bsky.social
Explore the latest data insights and performance indicator updates.
🔗 buff.ly/nkA9hR6
@natcan-news.bsky.social @targetovarian.bsky.social
Book to join on 9-11 July
👉https://bit.ly/3EQitw0
Book to join on 9-11 July
👉https://bit.ly/3EQitw0
www.natcan.org.uk/news/noca-ne...
@natcan-news.bsky.social
@targetovarian.bsky.social
www.natcan.org.uk/news/noca-ne...
@natcan-news.bsky.social
@targetovarian.bsky.social
We’ve secured a 2-year contract extension, taking us to Sept 2027.
Coming soon:
🔹QI interventions
🔹New website
🔹Revamped data dashboards
🔹Centre-level PPI forum
For more info: buff.ly/Dh2zgEX
Follow us to find out more about the impact of the audit on outcomes for women with ovarian cancer.
Visit the NOCA website for more info: www.natcan.org.uk/audits/ovari...
@targetovarian.bsky.social
Follow us to find out more about the impact of the audit on outcomes for women with ovarian cancer.
Visit the NOCA website for more info: www.natcan.org.uk/audits/ovari...
@targetovarian.bsky.social
bit.ly/4gJ3O43
@natcan-news.bsky.social @targetovarian.bsky.social
bit.ly/4gJ3O43
@natcan-news.bsky.social @targetovarian.bsky.social